Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: Population based cohort study of long term incidence and mortality

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Strander, Björn ^a,c   Hällgren, Jonas ^b   Sparén, Pär ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SWEDEN; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VAGINA CANCER;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SWEDEN; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; YOUNG ADULT;

EID: 84892753467     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f7361     Document Type: Article

References (36)

1. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, et al. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst 2009;101:88-99.
2. Arbyn M, Rebolj M, De Kok IM, Fender M, Becker N, O'Reilly M, et al. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 2009;45:2671-8.
3. Andrae B, Kemetli L, Sparen P, Silfverdal L, Strander B, Ryd W, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008;100:622-9.
4. McCredie MRE, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-34.
5. Strander B, Andersson-Ellstrom A, Milsom I, Sparén P. Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ 2007;335:1077.
6. Mitchell H, Medley G, Carlin JB. Risk of subsequent cytological abnormality and cancer among women with a history of cervical intraepithelial neoplasia: a comparative study. Cancer Causes Control 1990;1:143-8.
7. Pettersson F, Malker B. Invasive carcinoma of the uterine cervix following diagnosis and treatment of in situ carcinoma. Record linkage study within a National Cancer Registry. Radiother Oncol 1989;16:115-20. (Pubitemid 19258950)
8. Soutter WP, Sasieni P, Panoskaltsis T. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia. Int J Cancer 2006;118:2048-55.
9. Rapiti E, Usel M, Neyroud-Caspar I, Merglen A, Verkooijen HM, Vlastos AT, et al. Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III. Eur J Cancer 2012;48:845-52.
10. Swedish work and reference group for cervical cancer prevention within the Swedish Society of Obstetrics and Gynecology (C-ARG), ed. Cervical cancer prevention-guidelines for management, treatment and follow up of CIN. [Cervixcancerprevention-riktlinjer för utredning, behandling och uppföljning av cervikal intraepitelial neoplasi (CIN).] In Swedish. English summary, 2010.
11. Hakama M, Luostarinen T, Hakulinen T. Survival of in situ carcinoma of cervix uteri: a 50-year follow-up in Finland. Int J Cancer 2004;112:1072-4. (Pubitemid 39507016)
12. Kalliala I, Nieminen P, Dyba T, Pukkala E, Anttila A. Cancer free survival after CIN treatment: comparisons of treatment methods and histology. Gynecol Oncol 2007;105:228-33. (Pubitemid 46441467)
13. Jakobsson M, Gissler M, Paavonen J, Tapper AM. Long-term mortality in women treated for cervical intraepithelial neoplasia. BJOG 2009;116:838-44.
14. Kalliala I, Dyba T, Nieminen P, Hakulinen T, Anttila A. Mortality in a long-term follow-up after treatment of CIN. Int J Cancer 2010;126:224-31.
15. Barlow L, Westergren K, Holmberg L, Tallback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27-33.
16. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13. (Pubitemid 15028463)
17. Silfverdal L, Kemetli L, Sparen P, Andrae B, Strander B, Ryd W, et al. Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control study. Int J Cancer 2011;129:1450-8.
18. Noehr B, Jensen A, Frederiksen K, Tabor A, Kjaer SK. Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period. Am J Obstet Gynecol 2009;201:33.e1-6.
19. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008;337:a1284.
20. Mattsson B, Rutqvist LE, Wallgren A. Comparison between diagnoses in the Stockholm Regional Cancer Register and certified underlying causes of death. Acta Radiol Oncol 1985;24:219-26. (Pubitemid 15226721)
21. Fall K, Stromberg F, Rosell J, Andren O, Varenhorst E. Reliability of death certificates in prostate cancer patients. Scand J Urol Nephrol 2008;42:352-7.
22. Strander B. Cervical cancer prevention [thesis]. Gothenburg University, 2008.
23. Ronco G, Sideri MG, Ciatto S. Cervical intraepithelial neoplasia and higher long term risk of cancer. BMJ 2007;335:1053-4. (Pubitemid 350206259)
24. Cruickshank ME, Angus V, Kelly M, McPhee S, Kitchener HC. The case for stopping cervical screening at age 50. Br J Obstet Gynaecol 1997;104:586-9. (Pubitemid 27240426)
25. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93. (Pubitemid 36897941)
26. Van Wijngaarden WJ, Duncan ID. Rationale for stopping cervical screening in women over 50. BMJ 1993;306:967-71. (Pubitemid 23100017)
27. DeVeale B, Brummel T, Seroude L. Immunity and aging: the enemy within? Aging Cell 2004;3:195-208. (Pubitemid 40246684)
28. Sasieni PD, Cuzick J, Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 1996;73:1001-5. (Pubitemid 26116757)
29. Barken SS, Rebolj M, Andersen ES, Lynge E. Frequency of cervical intraepithelial neoplasia treatment in a well-screened population. Int J Cancer 2011;2011:26248.
30. Practice Bulletin. Screening for cervical cancer. Obstet Gynecol 2012;120:1222-38.
31. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26 suppl 10:K29-41.
32. Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, et al. HPV testing in primary screening of older women. Br J Cancer 1999;81:554-8. (Pubitemid 29458814)
33. Kocken M, Helmerhorst TJ, Berkhof J, Louwers JA, Nobbenhuis MA, Bais AG, et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. Lancet Oncol 12:441-50.
34. Legood R, Smith M, Lew JB, Walker R, Moss S, Kitchener H, et al. Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study. BMJ 2012;345:e7086.
35. Cruickshank ME, Sharp L, Chambers G, Smart L, Murray G. Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia. BJOG 2002;109:579-81. (Pubitemid 37338003)
36. Strander B, Ryd W, Wallin KL, Warleby B, Zheng B, Milsom I, et al. Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence? Eur J Cancer 2007;43:1849-55. (Pubitemid 47238251)